Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 10;23(16):8881. doi: 10.3390/ijms23168881

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Kaplan–Meier plots for patient prognosis when divided by ACBD3 mRNA expression. Black data points represent patients whose breast tumors had ACBD3 mRNA expression below the median level. Red data points represent patients whose breast tumors had ACBD3 mRNA expression above the median level. (a–d) Relapse-free survival when ACBD3 is high or low for (a) breast cancer patient cohort overall, (b) HER2− breast cancer patients, (c) ER+ breast cancer patients, (d) ER−breast cancer patients. (e,f) Overall survival when tumor ACBD3 is high or low for (e) the breast cancer patient cohort overall, (f) ER+ breast cancer patients. (g–i) Overall distant metastasis-free survival when tumor ACBD3 was high or low for (g) the breast cancer patient cohort overall, (h) HER2− breast cancer patients, (i) ER+ breast cancer patients.